Multimodal AI model for preoperative prediction of axillary lymph node metastasis in breast cancer using whole slide images.

Journal: NPJ precision oncology
Published Date:

Abstract

In breast cancer management, predicting axillary lymph node (ALN) metastasis using whole-slide images (WSIs) of primary tumor biopsies is a challenging and underexplored task for pathologists. We developed METACANS, an multimodal artificial intelligence (AI) model that integrates WSIs with clinicopathological features to predict ALN metastasis. METACANS was trained on 1991 cases and externally validated across five cohorts with a total of 2166 cases. Across all validation cohorts, METACANS achieved an area under the curve (AUC) of 0.733 (95% CI, 0.711-0.755), with an overall negative predictive value of 0.846, sensitivity of 0.820, specificity of 0.504, and balanced accuracy of 0.662. Without additional annotations, METACANS identified pathological imaging patterns linked to metastatic status, such as micropapillary growth, infiltrative patterns, and necrosis. While its predictive performance may not yet support immediate clinical application, METACANS addresses the task of predicting ALN metastasis using WSIs and clinicopathological features, and demonstrates the feasibility of multimodal AI approaches for preoperative axillary staging in breast cancer.

Authors

  • Doohyun Park
    School of Electrical and Electronic Engineering, Yonsei University, Seoul, Republic of Korea.
  • Yong-Moon Lee
    Department of Pathology, Dankook University College of Medicine, Cheonan, Republic of Korea.
  • Taejoon Eo
    School of Electrical and Electronic Engineering, Yonsei University, Seoul, Republic of Korea.
  • Hee Jung An
    Department of Pathology, CHA University, CHA Bundang Medical Center, Seongnam-si, Kyeonggi-do, Republic of Korea.
  • Haeyoun Kang
    Department of Pathology, CHA University, CHA Bundang Medical Center, Seongnam-si, Kyeonggi-do, Republic of Korea.
  • Eunhyang Park
    Department of Pathology, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Yoon Jin Cha
    Department of Pathology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Heejung Park
    Department of Pathology, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Dohee Kwon
    Department of Pathology, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Sun Young Kwon
    Department of Pathology, Keimyung University School of Medicine, Dongsan Hospital, Daegu, Republic of Korea.
  • Hye-Ra Jung
    Department of Pathology, Keimyung University School of Medicine, Dongsan Hospital, Daegu, Republic of Korea.
  • Su-Jin Shin
    Department of Pathology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Hyunjin Park
    Department of Pathology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Yangkyu Lee
    Department of Pathology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Sanghui Park
    Department of Pathology, Ewha Womans University College of Medicine, Seoul, Republic of Korea.
  • Ji Min Kim
    Department of Pathology, Ewha Womans University College of Medicine, Seoul, Republic of Korea.
  • Sung-Eun Choi
    Department of Pathology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Republic of Korea.
  • Nam Hoon Cho
    Department of Pathology, Yonsei University College of Medicine, Seoul, Republic of Korea. cho1988@yuhs.ac.
  • Dosik Hwang
    School of Electrical and Electronic Engineering, Yonsei University, Seoul, Republic of Korea. dosik.hwang@yonsei.ac.kr.

Keywords

No keywords available for this article.